0001437749-24-003012.txt : 20240202
0001437749-24-003012.hdr.sgml : 20240202
20240202190422
ACCESSION NUMBER: 0001437749-24-003012
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240131
FILED AS OF DATE: 20240202
DATE AS OF CHANGE: 20240202
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Barrett Elizabeth A.
CENTRAL INDEX KEY: 0001764157
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38079
FILM NUMBER: 24593449
MAIL ADDRESS:
STREET 1: C/O UROGEN PHARMA LTD.
STREET 2: 9 HA'TA'ASIYA STREET
CITY: RA'ANANA
STATE: L3
ZIP: 4365007
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: UroGen Pharma Ltd.
CENTRAL INDEX KEY: 0001668243
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: L3
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9 HA'TA'ASIYA ST
CITY: RA'ANANA
STATE: L3
ZIP: 4365007
BUSINESS PHONE: 972 9 770 7601
MAIL ADDRESS:
STREET 1: 9 HA'TA'ASIYA ST
CITY: RA'ANANA
STATE: L3
ZIP: 4365007
4
1
rdgdoc.xml
FORM 4
X0508
4
2024-01-31
0001668243
UroGen Pharma Ltd.
URGN
0001764157
Barrett Elizabeth A.
400 ALEXANDER PARK DRIVE
PRINCETON
NJ
08540
1
Chief Executive Officer
0
Restricted Stock Units
2024-01-31
4
A
0
87615
0
A
Ordinary Shares
87615
87615
D
Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer.
1/3 of the shares underlying the restricted stock units will vest on each of January 31, 2025, January 31, 2026 and January 31, 2027.
/s/ Jason D. Smith, Attorney-in-Fact
2024-02-02